South Korea Aesthetic Injectable Market Size & Outlook
South Korea aesthetic injectable market, 2018-2030 (US$M)
Related Markets
South Korea aesthetic injectable market highlights
- The South Korea aesthetic injectable market generated a revenue of USD 401.6 million in 2023 and is expected to reach USD 1,021.9 million by 2030.
- The South Korea market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
- In terms of segment, botulinum toxin was the largest revenue generating product in 2023.
- Hyaluronic Acid is the most lucrative product segment registering the fastest growth during the forecast period.
Aesthetic injectable market data book summary
| Market revenue in 2023 | USD 401.6 million |
| Market revenue in 2030 | USD 1,021.9 million |
| Growth rate | 14.3% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin |
| Fastest growing segment | Hyaluronic Acid |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 3.7% of the global aesthetic injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China aesthetic injectable market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,668.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aesthetic Injectable Market Scope
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea aesthetic injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.77% in 2023. Horizon Databook has segmented the South Korea aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea’s aesthetic injectable market is driven by the growing number of players entering into strategic partnerships and novel product launches.
For instance, in August 2023, LPharm Overseas Ltd., a UK-based distributor, and CGBio, a South Korean bio-regenerative medical company, entered into a collaboration through which CGBio’s HA-based dermal fillers would be launched in the international market.
HA dermal filler range would be sold under the brand AiLEENE and constitute three products with different viscosity & elasticity. Furthermore, the government aims to increase the footfall of foreign nationals undergoing cosmetic procedures in the country, which is expected to drive market growth.
Reasons to subscribe to South Korea aesthetic injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea aesthetic injectable market databook
-
Our clientele includes a mix of aesthetic injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into South Korea aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea aesthetic injectable market size, by product, 2018-2030 (US$M)
South Korea Aesthetic Injectable Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
